GDRX NASDAQ
GoodRx Holdings, Inc.
1W: -1.1%
1M: +5.1%
3M: +8.1%
YTD: +26.6%
1Y: -11.9%
3Y: -36.6%
5Y: -92.2%
$3.48
-0.08 (-2.25%)
Weekly Expected Move ±5.3%
$3
$3
$4
$4
$4
Credit Risk of going bust: higher than 67% of companies Debt: 31.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.15 (down 96%), GoodRx Holdings, Inc. would be worth roughly what it owes.
Total debt $539.0M against a stock market value of $1.19B.
Distance to default 3.62 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $245.8M (short-term plus half of long-term), stock volatility 55.9%; Altman Z'' -0.08. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.15 (down 96%), GoodRx Holdings, Inc. would be worth roughly what it owes.
Total debt $539.0M against a stock market value of $1.19B.
Distance to default 3.62 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $245.8M (short-term plus half of long-term), stock volatility 55.9%; Altman Z'' -0.08. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (24h)
1
Hourly Sentiment (24h)
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (100)
Icon PLC (ICLR) Q3 Earnings and Revenues Beat Estimates
173,450 Shares in GoodRx Holdings, Inc. $GDRX Acquired by VIRGINIA RETIREMENT SYSTEMS ET Al
Bank of New York Mellon Corp Invests $540,000 in GoodRx Holdings, Inc. $GDRX
HIMS Stock More Than Doubled in 6 Months: What's Driving the Rally?
GoodRx (GDRX) Q2 2026 Earnings Call Transcript
GoodRx (GDRX) Stock Jumps As Margins Strengthen And User Declines Linger - simplywall.st
GoodRx Q2 Earnings Call Highlights
GDRX Looks 42.2% Undervalued on GF Value™ - GuruFocus
GDRX Looks 42.2% Undervalued on GF Value™ - GuruFocus
GoodRx Holdings, Inc. (GDRX) Q2 Earnings Match Estimates
GoodRx Holdings, Inc. (GDRX) Q2 Earnings Match Estimates
GoodRx Holdings, Inc. (GDRX) Q2 Earnings Match Estimates - Yahoo Finance
GoodRx (GDRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
GoodRx (GDRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
GoodRx (GDRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
GoodRx (NASDAQ:GDRX) Reports Upbeat Q2 CY2026, Stock Soars - StockStory
GoodRx (NASDAQ:GDRX) Reports Upbeat Q2 CY2026, Stock Soars
GoodRx Holdings (NASDAQ: GDRX) elevates Justin Fengler to CFO role - Stock Titan
GoodRx (NASDAQ: GDRX) Q2 2026 revenue hits $200M as mix shifts - Stock Titan
GoodRx Reports Second Quarter 2026 Results
GoodRx’s Pharma Direct Revenue Rises 76% as Subscriptions Grow - Stock Titan
Ardent Health, Inc. (ARDT) Q2 Earnings Lag Estimates
Ardent Health, Inc. (ARDT) Q2 Earnings Lag Estimates
GoodRx Earnings: What To Look For From GDRX - StockStory
Goodrx Holdings Stock Price Forecast. Should You Buy GDRX? - StockInvest.us
Strength Seen in Labcorp (LH): Can Its 3.4% Jump Turn into More Strength?
Strength Seen in Labcorp (LH): Can Its 3.4% Jump Turn into More Strength?
1 Cash-Producing Stock for Long-Term Investors and 2 We Avoid
Trump outlines plans for up to 200% tariffs on generic drug imports starting in 2028
GoodRx (GDRX): Buy, Sell, or Hold Post Q1 Earnings?
GoodRx Holdings, Inc. (NASDAQ:GDRX) Given Average Rating of “Hold” by Brokerages
1 Profitable Stock for Long-Term Investors and 2 Facing Challenges
Stocks making big moves yesterday: RXO, Progyny, Cigna, GoodRx, and Domino's
GoodRx (GDRX) Stock Trades Up, Here Is Why
GoodRx (GDRX) Stock Trades Up, Here Is Why - Yahoo Finance
GoodRx Holdings (GDRX) Pharma Growth Story Meets A Small Fair Value Gap
GoodRx (GDRX) Stock Looks Full On Earnings But Mixed On Value
GoodRx (GDRX) Stock Looks Full On Earnings But Mixed On Value - Yahoo Finance
GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call
1 Mooning Stock to Target This Week and 2 That Underwhelm
GoodRx (GDRX) Upgraded to Buy: What Does It Mean for the Stock?
GoodRx (GDRX) Upgraded to Buy: What Does It Mean for the Stock?
GDRX or HQY: Which Is the Better Value Stock Right Now?
GDRX or HQY: Which Is the Better Value Stock Right Now?
Is GoodRx (GDRX) Stock Undervalued Right Now?
Is GoodRx (GDRX) Stock Undervalued Right Now?
Is GoodRx (GDRX) Stock Undervalued Right Now? - Yahoo Finance
[Latest] Global Healthcare Discount Plan Market Size/Share Worth USD 48.37 Billion by 2035 at a 8.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
GDRX Forecast — Price Target — Prediction for 2027 - TradingView
Biodesix (BDSX) Surges 10.5%: Is This an Indication of Further Gains?
GoodRx Holdings, Inc. (GDRX) Strengthens Recurring Revenue Base with Companion
How The Shifting Story For GoodRx (GDRX) Is Reshaping Analyst Views And Valuation - Yahoo Finance
SA analyst upgrades/downgrades: NVDA, META, GDRX, JPM
Hims & Hers Deepens Personalized Care Through Platform Expansion
OptimizeRx Cuts Revenue Outlook: Will Pressures Ease Ahead?
GoodRx vs. Hims & Hers Health: Stagnation vs. Growth in Revenue
GoodRx (GDRX) Q1 2026 Earnings Call Transcript
GoodRx raises 2026 outlook to $765M-$785M revenue and at least $235M adjusted EBITDA, led by Pharma Direct
Should You Add OPRX Stock to Your Portfolio Pre-Q1 Earnings?
GoodRx (GDRX) Stock Trades Up, Here Is Why - StockStory
GoodRx (GDRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
GoodRx Holdings, Inc. (GDRX) Q1 Earnings Match Estimates
Earnings Scheduled For May 6, 2026
GoodRx Holdings, Inc. (GDRX) Q1 Earnings Match Estimates - Yahoo Finance
Hims & Hers Expands Digital-First Access to Personalized Healthcare
Sandisk and Whirlpool have been highlighted as Zacks Bull and Bear of the Day
Tempus AI Nears Profitability as Operating Leverage Emerges
OptimizeRx vs. GoodRx: Which Digital Health Stock is the Better Buy?
HIMS Plunges 51.2% in 6 Months: Should You Still Hold the Stock or Sell?
GoodRx Rallies As Wegovy HD Rollout Targets Self-Pay Market
Why GoodRx (GDRX) Stock Is Up Today - Yahoo Finance
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Average Rating of “Hold” from Brokerages
What's Going On With GoodRx Stock Thursday?
Hims & Hers Advances a Consumer-Centric Digital Health Platform
GoodRx Holdings, Inc. (NASDAQ:GDRX) Short Interest Update
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Average Rating of “Hold” from Brokerages
HIMS Expands Personalized Digital Healthcare Access and Services
GoodRx to offer up to 85% discount on Viatris drugs
Lilly launches program to drive employee access to obesity care
GoodRx, a turn around opportunity. ($GDRX)
Hims & Hers Expands Digital Health and Global Platform Strategy
GoodRx expects Pharma Direct revenue growth of at least 30% in 2026 amid shift to pharma manufacturer solutions
GoodRx Holdings, Inc. (GDRX) Q4 2025 Earnings Call Transcript
GoodRx Targets Digital Subscription Growth Amid 14% Dip in Active Consumers
Here's What Key Metrics Tell Us About GoodRx (GDRX) Q4 Earnings
GoodRx Holdings Non-GAAP EPS of $0.09 in-line, revenue of $195M beats by $1.73M
GoodRx Reports Fourth Quarter and Full Year 2025 Results
GoodRx Expands Into Employer Market With Launch of “GoodRx Employer Direct”
GoodRx Powers Pricing for Leading Brand Medications on TrumpRx
GoodRx Earns HITRUST i1 Certification for the Second Consecutive Year, Reinforcing Its Commitment to Protecting Healthcare Data at Scale
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership
GoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
GoodRx Holdings, Inc. (GDRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Surescripts and GoodRx Partner to Advance Patient Price Transparency
GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies
GoodRx Now Offers Novo Nordisk's Cash Price for the Launch of the Wegovy® Pill
Q Biomed (OTCMKTS:QBIO) & GoodRx (NASDAQ:GDRX) Financial Survey
COMPASS Pathways (NASDAQ:CMPS) and GoodRx (NASDAQ:GDRX) Financial Analysis
Head to Head Analysis: Embecta (NASDAQ:EMBC) vs. GoodRx (NASDAQ:GDRX)
GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference